Skip to main contentSkip to navigation
Sirius Investors

CHJTF Stock: CSPC Pharmaceutical Group Limited Stock Price, Analysis & Insights

Get live CHJTF stock price $1.05, comprehensive CSPC Pharmaceutical Group Limited stock analysis, charts, news, and expert forecast. Real-time CHJTF stock data and investment insights.

1.05
0.00%Today
CHJTFCSPC Pharmaceutical Group Limited • Other OTC • Healthcare
Market Cap
11.98B
Volume
0
52W High
1.39
52W Low
0.54

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

CSPC Pharmaceutical Group Limited operates as an investment holding company with a core focus on the research, development, manufacturing, and global commercialization of pharmaceutical products. Its extensive operations span the People's Republic of...

Company Information

CEO
Lei Cai
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
21400

Contact Information

Address
No. 226 Huanghe Street
Country
CN

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - General

Investment Highlights

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 21.0)

Lower volatility stock (Beta: 0.73) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for CSPC Pharmaceutical Group Limited shareholders
  • Market volatility can significantly impact stock price, especially for mid-cap stocks
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for CSPC Pharmaceutical Group Limited
  • Investors should consider how CSPC Pharmaceutical Group Limited fits within their overall portfolio allocation

Market Cap

11.98B

P/E Ratio (TTM)

21.00

Beta

0.73

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.